<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261897</url>
  </required_header>
  <id_info>
    <org_study_id>SM2-PJ-10</org_study_id>
    <secondary_id>2010-021918-30</secondary_id>
    <nct_id>NCT01261897</nct_id>
  </id_info>
  <brief_title>The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty</brief_title>
  <official_title>The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the efficacy of Adductor-Canal-Blockade on pain and
      morphine consumption after total knee arthroplasty. Our hypothesis is that the Adductor
      -Canal-Blockade is superior to placebo in reducing pain and morphine consumption after total
      knee arthroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain during 45 degrees active flexion of the knee</measure>
    <time_frame>1 hour postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), at 1 hour postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain during 45 degrees active flexion of the knee</measure>
    <time_frame>0-6 hours postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), registered at the intervals 1, 2, 3, 4, 5 and 6 hours postoperative, calculated as &quot;the area under the curve&quot; (AUC) for the interval 1-6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during rest</measure>
    <time_frame>1-6 hours postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), registered at the intervals 1, 2, 3, 4, 5 and 6 hours postoperative, calculated as &quot;the area under the curve&quot; (AUC) for the interval 1-6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A change in pain score in the ropivacaine group, after activating the block</measure>
    <time_frame>30-60 minutes postoperative</time_frame>
    <description>0-100 mm at a visual analogue scale (VAS), at 30 and 60 minutes postoperative. A change in pain score in the ropivacaine group compared to the placebo group, after activating the block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>30 minutes - 6 hours postoperative</time_frame>
    <description>Total morphine consumption at the interval 30 minutes - 6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>1-6 hours postoperative</time_frame>
    <description>Nausea scores(0-3)registered at 1, 2, 3, 4, 5 and 6 hours postoperative, calculated as mean value for the interval 1-6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative vomiting</measure>
    <time_frame>1-6 hours postoperative</time_frame>
    <description>Number of vomiting episodes at the interval 1-6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zofran consumption</measure>
    <time_frame>1-6 hours postoperative</time_frame>
    <description>Total zofran consumption at the intervals 1-6 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>1-6 hours postoperative</time_frame>
    <description>Sedation score (0-3) registered at 1, 2, 3, 4, 5 and 6 hours postoperative, calculated as the mean value for the interval 1-6 hours postoperative.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Adductor-Canal-Blockade with Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor-Canal-blockade with saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor-Canal-Blockade with Ropivacaine</intervention_name>
    <description>US-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml</description>
    <arm_group_label>Adductor-Canal-Blockade with Ropivacaine</arm_group_label>
    <other_name>Naropine</other_name>
    <other_name>Postoperative pain</other_name>
    <other_name>US-guided nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor-Canal-blockade with saline</intervention_name>
    <description>US-guided Adductor-Canal-blockade with saline</description>
    <arm_group_label>Adductor-Canal-blockade with saline</arm_group_label>
    <other_name>Sham block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Total Knee Arthroplasty in general anaesthesia

          -  ASA 1-3

          -  BMI 18-40

          -  Written informed consent

        Exclusion Criteria:

          -  Can not cooperate to the exam

          -  Do not speak or understand Danish

          -  Drug allergy

          -  Alcohol or drug abuse

          -  Daily consumption of strong opioids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pia JÃ¦ger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesia-Surgery-Intensive Care, Gentofte Hospital</name>
      <address>
        <city>Gentofte</city>
        <state>Hellerup</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2010</study_first_submitted>
  <study_first_submitted_qc>December 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2010</study_first_posted>
  <last_update_submitted>October 3, 2011</last_update_submitted>
  <last_update_submitted_qc>October 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 4, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Pia Jaeger</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Adductor-Canal-Blockade</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>US-guided nerve block</keyword>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

